Fluvoxamine in the treatment of panic disorder: a multi-center, double-blind, placebo-controlled study in outpatients

@article{Asnis2001FluvoxamineIT,
  title={Fluvoxamine in the treatment of panic disorder: a multi-center, double-blind, placebo-controlled study in outpatients},
  author={G. Asnis and Faiq A. Hameedi and A. Goddard and S. Potkin and S. Woods},
  journal={Psychiatry Research},
  year={2001},
  volume={103},
  pages={1-14}
}
  • G. Asnis, Faiq A. Hameedi, +2 authors S. Woods
  • Published 2001
  • Medicine, Psychology
  • Psychiatry Research
  • Serotonergic mechanisms have been implicated in panic disorder, and several preliminary studies suggest that fluvoxamine, a selective serotonin reuptake inhibitor (SSRI), is helpful in its treatment. This 8-week double-blind parallel-group study compared fluvoxamine with a placebo in 188 patients with DSM-III-R defined panic disorder with or without agoraphobia. Efficacy assessments included a Daily Panic Attack Inventory, the Sheehan Disability Scale, the Clinical Anxiety Scale and the… CONTINUE READING
    Fluvoxamine in the treatment of anxiety disorders
    • 36
    • Highly Influenced
    Mirtazapine in the treatment of panic disorder: an open-label trial
    • 34

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 53 REFERENCES
    Effect of fluvoxamine on panic disorder.
    • 105
    A new depression scale designed to be sensitive to change.
    • 10,040